Ionic Ventures LLC 13D and 13G filings for Biodexa Pharmaceuticals Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:47 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Ionic Ventures LLC | 5,421 4.900% | 5,421 (New Position) | Filing |